These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21193036)

  • 21. Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11β-hydroxylase and aldosterone synthase.
    Akram M; Patt M; Kaserer T; Temml V; Waratchareeyakul W; Kratschmar DV; Haupenthal J; Hartmann RW; Odermatt A; Schuster D
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105358. PubMed ID: 30965118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of the -344C/T polymorphism of the aldosterone synthase gene (CYP11B2) in cardiovascular diseases].
    Boduła A; Dołyk A; Protasiewicz J; Adamiec R
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():838-47. PubMed ID: 18202594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors.
    LaSala D; Shibanaka Y; Jeng AY
    Anal Biochem; 2009 Nov; 394(1):56-61. PubMed ID: 19622340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity.
    Heim R; Lucas S; Grombein CM; Ries C; Schewe KE; Negri M; Müller-Vieira U; Birk B; Hartmann RW
    J Med Chem; 2008 Aug; 51(16):5064-74. PubMed ID: 18672861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors.
    Meguro M; Miyauchi S; Kanao-Arisumi Y; Naito S; Suzuki K; Inoue S; Yamada K; Homma T; Chiba K; Nara F; Furuzono S
    Bioorg Med Chem; 2024 Jun; 108():117775. PubMed ID: 38851000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of Potential Inhibitors of Aldosterone Synthase from Chinese Herbs Using Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Studies.
    Luo G; Lu F; Qiao L; Chen X; Li G; Zhang Y
    Biomed Res Int; 2016; 2016():4182595. PubMed ID: 27781210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-Phenylsulfinyl-3-(pyridin-3-yl)naphthalen-2-ols: a new class of potent and selective aldosterone synthase inhibitors.
    Grombein CM; Hu Q; Heim R; Rau S; Zimmer C; Hartmann RW
    Eur J Med Chem; 2015 Jan; 89():597-605. PubMed ID: 25462268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of Novel Pyrazole-Based Selective Aldosterone Synthase (CYP11B2) Inhibitors: A New Template to Coordinate the Heme-Iron Motif of CYP11B2.
    Sakakibara R; Sasaki W; Onda Y; Yamaguchi M; Ushirogochi H; Hiraga Y; Sato K; Nishio M; Egi Y; Takedomi K; Shimizu H; Ohbora T; Akahoshi F
    J Med Chem; 2018 Jul; 61(13):5594-5608. PubMed ID: 29878770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel pyridyl- or isoquinolinyl-substituted indolines and indoles as potent and selective aldosterone synthase inhibitors.
    Yin L; Hu Q; Emmerich J; Lo MM; Metzger E; Ali A; Hartmann RW
    J Med Chem; 2014 Jun; 57(12):5179-89. PubMed ID: 24899257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fission yeast Schizosaccharomyces pombe as a new system for the investigation of corticosterone methyloxidase deficiency-causing mutations.
    Tin MK; Hakki T; Bernhardt R
    J Steroid Biochem Mol Biol; 2011 Mar; 124(1-2):31-7. PubMed ID: 21237269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging trends in small molecule inhibitors targeting aldosterone synthase: A new paradigm in cardiovascular disease treatment.
    Guo C; Zhang G; Wu C; Lei Y; Wang Y; Yang J
    Eur J Med Chem; 2024 Aug; 274():116521. PubMed ID: 38820853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice.
    Gu H; Ma Z; Wang J; Zhu T; Du N; Shatara A; Yi X; Kowala MC; Du Y
    Sci Rep; 2017 Mar; 7(1):492. PubMed ID: 28352088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel aldosterone synthase inhibitor ameliorates mortality in pressure-overload mice with heart failure.
    Furuzono S; Meguro M; Miyauchi S; Inoue S; Homma T; Yamada K; Tagawa YI; Nara F; Nagayama T
    Eur J Pharmacol; 2017 Jan; 795():58-65. PubMed ID: 27915044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics.
    Roumen L; Sanders MP; Pieterse K; Hilbers PA; Plate R; Custers E; de Gooyer M; Smits JF; Beugels I; Emmen J; Ottenheijm HC; Leysen D; Hermans JJ
    J Comput Aided Mol Des; 2007 Aug; 21(8):455-71. PubMed ID: 17646925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhesus monkey model for concurrent analyses of in vivo selectivity, pharmacokinetics and pharmacodynamics of aldosterone synthase inhibitors.
    Cai TQ; Stribling S; Tong X; Xu L; Wisniewski T; Fontenot JA; Struthers M; Akinsanya KO
    J Pharmacol Toxicol Methods; 2015; 71():137-46. PubMed ID: 25304940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discovery of potent inhibitors of aldosterone synthase that exhibit selectivity over 11-beta-hydroxylase.
    Adams CM; Hu CW; Jeng AY; Karki R; Ksander G; Lasala D; Leung-Chu J; Liang G; Liu Q; Meredith E; Rao C; Rigel DF; Shi J; Smith S; Springer C; Zhang C
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4324-7. PubMed ID: 20615692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity.
    Meyers K; Cogan DA; Burke J; Arenas R; Balestra M; Brown NF; Chen Z; Cerny MA; Clifford HE; Colombo F; Fader L; Frederick KS; Guo X; Goldberg D; Hornberger KR; Kugler S; Lord J; Marshall DR; Moss N; Parmentier JH; Richman JR; Schmenk J; Weldon SM; Yu M; Zhang M
    Bioorg Med Chem Lett; 2018 Mar; 28(5):979-984. PubMed ID: 29254646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacophore Modeling and
    Akram M; Waratchareeyakul W; Haupenthal J; Hartmann RW; Schuster D
    Front Chem; 2017; 5():104. PubMed ID: 29312923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldosterone: from biosynthesis to non-genomic action onto the proteome.
    Zöllner S; Hwang KH; Wilzewski B; Carapito C; Leize-Wagner E; Van Dorsselaer A; Bernhardt R
    Steroids; 2008 Oct; 73(9-10):966-72. PubMed ID: 18280527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress towards clinically useful aldosterone synthase inhibitors.
    Cerny MA
    Curr Top Med Chem; 2013; 13(12):1385-401. PubMed ID: 23688131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.